Cardia, Inc. is a medical technology company dedicated to developing and commercializing innovative, less-invasive catheter-based medical devices for the treatment of structural heart disease. Their focus is on providing physicians with advanced tools to improve patient outcomes, particularly in addressing conditions like atrial septal defects (ASDs) and patent foramen ovale (PFO). Cardia emphasizes research, development, and clinical excellence to bring next-generation cardiac therapies to market.
Serves as the primary hub for research and development, manufacturing, corporate administration, and strategic operations for Cardia, Inc.
The facility likely includes state-of-the-art research laboratories, cleanroom environments for medical device manufacturing, and engineering design centers.
A culture of innovation, collaboration, and precision, driven by a commitment to advancing medical science and improving patient lives in the cardiovascular field.
Strategically located in the Minneapolis-St. Paul metropolitan area, a prominent medtech innovation hub known as 'Medical Alley,' providing access to a rich talent pool and industry ecosystem.
Cardia, Inc. extends its reach globally through a network of distribution partners and direct sales efforts in key international markets, including North America and Europe. The company actively engages with the international cardiology community, participates in global medical conferences, and collaborates with key opinion leaders worldwide to ensure its innovative structural heart solutions are available to patients in need across various regions.
12900 Whitewater Drive, Suite 100
Minnetonka
Minnesota
United States
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Cardia' leadership includes:
Cardia has been backed by several prominent investors over the years, including:
Cardia, Inc. has maintained a stable core executive team over the past 12 months. No major high-profile executive hires or departures have been publicly announced, indicating continuity in leadership focused on the company's strategic objectives in the structural heart device market.
Discover the tools Cardia uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats at Cardia, Inc. likely follow standard corporate patterns. The most probable format involves a combination of the employee's first initial and last name.
[first_initial][last]@cardia.com
Format
rkieval@cardia.com
Example
75%
Success rate
Cardia, Inc. Press Release • January 11, 2023
Cardia, Inc. reported the first successful human implants of its AVATAR™ Transcatheter Septal Occluder, a next-generation device designed for minimally invasive closure of atrial septal defects (ASDs). This marks a significant milestone in the product's development and clinical application....more
Cardia, Inc. Press Release • November 2, 2022
Cardia, Inc. announced it received CE Mark approval for its AVATAR™ Transcatheter Septal Occluder System, enabling commercialization in European countries that recognize the CE Mark. The company also reported the first successful implants of the device in Europe, expanding its market reach....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Cardia, are just a search away.